recommended reading

Boston Considers Banning Deadliest Pathogens From New Biolab


Boston is set this week to debate whether to ban a new, downtown biodefense laboratory from studying some of the world's deadliest disease agents.

A Wednesday city council hearing is expected to consider a proposed citywide prohibition on so-called "Biosafety Level 4" research, which can involve diseases for which there are no known cures. The initiative marks the latest local pushback against Boston University's effort to pursue the sensitive pathogen studies at its recently completed National Emerging Infectious Diseases Laboratories.

In his draft ordinance, Councilor Charles Yancey said conducting such research at the site could enable an agent such as Ebola or Marburg to escape into the city, either by accident or deliberate action.

"I am not convinced we really need to invite that possibility to the city of Boston," Yancey told the Boston Globe in remarks published in a Sunday editorial.

Boston University has criticized the rationale behind the council measure, arguing that the laboratory's security is stringent and any sensitive research justified by the need to prepare against lethal disease agents.

A four-year risk study "considered hundreds of possible scenarios that could potentially result in an exposure of a worker to a pathogen, or the release of a biological agent [and] demonstrated conclusively that BSL-4 laboratories -- built with multiple backup redundancies for its operations systems -- are extremely safe," the university said in a statement last month.

Sunday's Globe editorial sides with the school, and argues that the site's location would facilitate collaboration with experts throughout the region.

"It's understandable why critics of the biolab might prefer that the research take place in an isolated facility ... [but that] would impede scientists' ability to learn from one another," the newspaper said.

Threatwatch Alert

Thousands of cyber attacks occur each day

See the latest threats


Close [ x ] More from Nextgov

Thank you for subscribing to newsletters from
We think these reports might interest you:

  • Data-Centric Security vs. Database-Level Security

    Database-level encryption had its origins in the 1990s and early 2000s in response to very basic risks which largely revolved around the theft of servers, backup tapes and other physical-layer assets. As noted in Verizon’s 2014, Data Breach Investigations Report (DBIR)1, threats today are far more advanced and dangerous.

  • Featured Content from RSA Conference: Dissed by NIST

    Learn more about the latest draft of the U.S. National Institute of Standards and Technology guidance document on authentication and lifecycle management.

  • PIV- I And Multifactor Authentication: The Best Defense for Federal Government Contractors

    This white paper explores NIST SP 800-171 and why compliance is critical to federal government contractors, especially those that work with the Department of Defense, as well as how leveraging PIV-I credentialing with multifactor authentication can be used as a defense against cyberattacks

  • Toward A More Innovative Government

    This research study aims to understand how state and local leaders regard their agency’s innovation efforts and what they are doing to overcome the challenges they face in successfully implementing these efforts.

  • From Volume to Value: UK’s NHS Digital Provides U.S. Healthcare Agencies A Roadmap For Value-Based Payment Models

    The U.S. healthcare industry is rapidly moving away from traditional fee-for-service models and towards value-based purchasing that reimburses physicians for quality of care in place of frequency of care.

  • GBC Flash Poll: Is Your Agency Safe?

    Federal leaders weigh in on the state of information security


When you download a report, your information may be shared with the underwriters of that document.